top of page
  • Facebook
  • Twitter
  • Instagram
< Back

N.E.M.O. NEUROBORRELIOSIS PAIN AXIS

Laboratory Description


This ampoule set is designed as a comprehensive multi-layer system targeting chronic pain and neuroinflammation associated with Borrelia burgdorferi, with a specific focus on neuroborreliosis affecting cranial nerves (especially trigeminal nerve), oral cavity structures (gums, teeth, jaw), muscular tension, and peripheral and central nervous system dysregulation.


Each ampoule represents a functional pathological pathway involved in chronic infection, biofilm persistence, neurotoxicity, and pain signaling.



I. BORRELIA BURGDORFERI - FULL SPECTRUM

1.N.E.M.O. Borrelia burgdorferi spirochete form - neuroinvasive

2. N.E.M.O. Borrelia burgdorferi cystic form - persistent survival

3. N.E.M.O. Borrelia burgdorferi L-form - cell wall deficient

4. N.E.M.O. Borrelia burgdorferi intracellular form - immune evasion

5. N.E.M.O. Borrelia burgdorferi biofilm form - chronic protection

6. N.E.M.O. Borrelia burgdorferi neurotropic strain

7. N.E.M.O. Borrelia burgdorferi central nervous system involvement

8. N.E.M.O. Borrelia burgdorferi peripheral nervous system involvement

9. N.E.M.O. Borrelia burgdorferi cranial nerves targeting

10. N.E.M.O. Borrelia burgdorferi autonomic nervous system dysregulation


II. NEUROBORRELIOSIS - NEUROINFLAMMATION

11. N.E.M.O. Neuroborreliosis - chronic neuroinflammation pathway

12. N.E.M.O. Neuroborreliosis - microglial activation

13. N.E.M.O. Neuroborreliosis - neurotoxicity cascade

14. N.E.M.O. Neuroborreliosis - demyelination pathway

15. N.E.M.O. Neuroborreliosis - synaptic dysfunction

16. N.E.M.O. Neuroborreliosis - pain signal amplification

17. N.E.M.O. Neuroborreliosis - neuroimmune dysregulation

18. N.E.M.O. Neuroborreliosis - cytokine storm local (neural tissue)


III. TRIGEMINAL NERVE - FULL PAIN SYSTEM

19. N.E.M.O. Trigeminal nerve inflammation

20. N.E.M.O. Trigeminal neuralgia - chronic pain pattern

21. N.E.M.O. Trigeminal nerve compression pathway

22. N.E.M.O. Trigeminal nerve hypersensitivity

23. N.E.M.O. Trigeminal nerve viral/bacterial co-infection sensitivity

24. N.E.M.O. Trigeminal ganglion inflammation

25. N.E.M.O. Trigeminal nerve demyelination

26. N.E.M.O. Facial nerve pain cross-activation

27. N.E.M.O. Cranial nerve V sensory overload


IV. ORAL & DENTAL AXIS

28. N.E.M.O. Oral cavity chronic infection - neurogenic link

29. N.E.M.O. Gum inflammation - neuroinflammatory connection

30. N.E.M.O. Dental nerve pain - Borrelia-associated

31. N.E.M.O. Jaw bone inflammation (mandible/maxilla)

32. N.E.M.O. Periodontal neurotoxicity pathway

33. N.E.M.O. Dental biofilm - chronic infection matrix

34. N.E.M.O. Oral-spinal neural connection pathway


V. MUSCULAR & FASCIAL PAIN SYSTEM

35. N.E.M.O. Muscle neuroinflammation - Borrelia related

36. N.E.M.O. Chronic muscle tension - neurogenic origin

37. N.E.M.O. Myofascial pain - trigeminal-linked

38. N.E.M.O. Neck and jaw muscle contraction pattern

39. N.E.M.O. Fascia inflammation - systemic neurotoxicity

40. N.E.M.O. Muscle toxin accumulation - infection-related


VI. PAIN & SIGNALING PATHWAYS

41. N.E.M.O. Neuropathic pain pathway - chronic activation

42. N.E.M.O. Pain signal amplification - central sensitization

43. N.E.M.O. Peripheral nerve hypersensitivity

44. N.E.M.O. Neurotransmitter imbalance - pain modulation

45. N.E.M.O. Chronic pain memory imprint

46. N.E.M.O. Autonomic nervous system pain dysregulation


VII. BIOFILM & TOXIN SYSTEM

47. N.E.M.O. Borrelia multispecies biofilm matrix

48. N.E.M.O. Neurotoxin release - Barrel

49. N.E.M.O. Endotoxin-induced nerve irritation

50. N.E.M.O. Biofilm-induced neural protection barrier


VIII. REGENERATION & NERVE SUPPORT

50. N.E.M.O. Nerve regeneration pathway

51. N.E.M.O. Myelin repair pathway

52. N.E.M.O. Neural signal stabilization

53. N.E.M.O. Anti-neuroinflammatory regulation

54. N.E.M.O. Trigeminal nerve recovery pathway


FINAL NOTE FOR LAB

All ampoules must represent functional biological and pathological pathways, not isolated substances.

Each ampoule should include multi-layer interaction: pathogen presence, neuroinflammation, biofilm, toxin influence, and nervous system response.

No duplication across ampoules.

Next

© 2035 by N.E.M.O. 

bottom of page